Dutch flooring resists chemicals
Bolidt Synthetic Products and Systems of the Netherlands has launched a new synthetic flooring finish designed specifically to cope with aggressive chemical and pharmaceutical production environments.
Archives for June 23, 2004
Roche, GSK ramp up production
Swiss pharmaceuticals company Roche said it is investing 800 million Swiss francs (€530 million) to build two new manufacturing facilities in Europe.
Ernst & Young on pharma re-imports, pricing
The pharmaceutical industry must tackle the issue of pricing disparity between countries if it is to avoid having the matter taken out of its hands by government-mandated price cuts and parallel imports.
Ranbaxy launches chewable cefaclor
The US subsidiary of India's Ranbaxy has launched a cephalosporin antibiotic in a chewable tablet formulation designed to be easier to take by patients who struggle with tablets or capsules.
Buccal delivery shows further promise
Canada's Generex Biotechnology has presented new evidence that its RapidMist device can deliver proteins and peptides through the lining of the mouth, potentially doing away with the need for injections.
China proving tough nut for foreign firms?
Foreign drugmakers are failing to win ground against their local counterparts in China, despite investing considerable sums in the country over the last few years.
Euro drug companies plan R&D cooperation
A group of research directors of leading pharmaceutical companies met this week to agree a framework for working together on research in a bid to make the European industry more competitive.
New UK centre for stem cell research
The world's largest centre for human embryonic stem cell research, which will develop treatments for a range of currently incurable diseases, is to be opened by Cambridge University in the UK.